Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Samantha Di Donato
Benefit From Anti-EGFRs in RAS and BRAF Wild-Type Metastatic Transverse Colon Cancer: A Clinical and Molecular Proof of Concept Study
ESMO Open
Cancer Research
Oncology
DPYD*6 Plays an Important Role in Fluoropyrimidine Toxicity in Addition to DPYD*2A and C.2846A>T: A Comprehensive Analysis in 1254 Patients
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Related publications
RAS and BRAF in Metastatic Colorectal Cancer Management
Journal of Gastrointestinal Oncology
Oncology
Gastroenterology
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-Line Cetuximab and Irinotecan
JAMA Oncology
Cancer Research
Oncology
Sequential HER2 Blockade as Effective Therapy in Chemorefractory, HER2 Gene-Amplified, RAS Wild-Type, Metastatic Colorectal Cancer: Learning From a Clinical Case
ESMO Open
Cancer Research
Oncology
Mutant and Wild-Type Ras: Co-Conspirators in Cancer
Cancer Discovery
Oncology
Relationship Between Tumour Response and Tumour-Related Symptoms in RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses From 3 Panitumumab Trials
Clinical Colorectal Cancer
Oncology
Gastroenterology
Impact of Tumour RAS/BRAF Status in a First-Line Study of Panitumumab + FOLFIRI in Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
PTEN Gene Expression and Mutations in the PIK3CA Gene as Predictors of Clinical Benefit to Anti-Epidermal Growth Factor Receptor Antibody Therapy in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer
World Journal of Surgical Oncology
Surgery
Oncology
The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-Ras Mutation Status: Analysis of a Phase III Study of Bevacizumab With Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
